Skip to main content

Rossmore Private Capital

Position in GILD — Gilead Sciences, Inc.

CIK 1733082 GLASTONBURY, CT

Position in GILD

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$597,840
-$68,627 QoQ
Shares Held
4,732
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,299
of 2,266 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$379,020
PutShares
3,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Rossmore Private Capital holds $82,109,326 across 11 Drug Manufacturers - General names. GILD ranks #10 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $597,840 4,732
2026-06-30 $379,020 3,000
2026-03-31 $666,467 4,782
2026-03-31 $390,236 2,800
2025-12-31 $513,298 4,182
2025-12-31 $294,576 2,400
2025-09-30 $442,002 3,982
2025-06-30 $441,484 3,982
2024-03-31 $416,499 5,686
2023-12-31 $468,723 5,786
2023-09-30 $431,729 5,761
2023-06-30 $467,121 6,061
2023-03-31 $668,821 8,061
2022-12-31 $692,036 8,061
2022-09-30 $476,802 7,729
2022-06-30 $477,729 7,729
2022-03-31 $435,709 7,329
2021-12-31 $557,572 7,679
2021-09-30 $536,378 7,679
2021-06-30 $597,635 8,679
2021-03-31 $560,923 8,679
2020-12-31 $450,000 7,724
2020-09-30 $281,953 4,462
2020-06-30 $341,305 4,436